Hoth Therapeutics Inc

HOTH NASDAQ Healthcare & Biotech United States US44148G1058
1.29 $
7.19 %

Hoth Therapeutics Inc is committed to developing new biologic therapies to treat dermatological diseases.

Price history of Hoth Therapeutics Inc
Price history of Hoth Therapeutics Inc

Performance & Momentum

6 Months 79.83 %
1 Year 39.87 %
3 Years 13.83 %
5 Years 94.48 %

Strategic Analysis

Hoth Therapeutics Inc • 2026

Hoth Therapeutics Inc positions itself as a specialist player in the development of innovative biologic therapies for dermatological diseases, a niche segment with strong medical potential. Its model is based on targeted biotechnological advances aimed at addressing specific unmet needs in dermatological healthcare.

Strengths
  • Focus on innovative biologic treatments in a sector with high regulatory barriers
  • Dermatology niche offering differentiated specialization
  • Growth potential linked to innovation in an underpenetrated skin disease market
Weaknesses
  • Marked historical volatility with negative performance over the medium and long term
  • Lack of recent significant news to support valuation momentum
Momentum

Current momentum signals a short-term rebound after a difficult period, reflecting a potential renewed interest from investors. However, past volatility suggests caution, and the strategic positioning will need time to translate into stable gains.

Similar stocks to Hoth Therapeutics Inc

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone